LAZARI CAPITAL MANAGEMENT, INC.

Position in MESO — Mesoblast Ltd

CIK 1986389 WOODLAND HILLS, CA

Position in MESO

as of Mar 31, 2026 · filed Apr 24, 2026 Compact

Position Value

$709,340

-$122,682 QoQ

Shares Held

46,121

0.0% QoQ

Ownership

0.036%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

LAZARI CAPITAL MANAGEMENT, INC. holds $911,419 across 5 Biotechnology names. MESO ranks #1 (77.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MESO	Mesoblast Ltd This page	46,121	$709,340
2	GERN	Geron Corp	112,424	$167,511
3	LCTX	Lineage Cell Therapeutics, Inc.	10,500	$16,590
4	VANI	Vivani Medical, Inc.	10,000	$10,000
5	HUMA	Humacyte, Inc.	13,144	$7,978

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$709,340	46,121	0.0%	Shares	Sole	2026-04-24
2025-12-31	$832,022	46,121	-1.2%	Shares	Sole	2026-01-29
2025-09-30	$751,869	46,671	+0.4%	Shares	Sole	2025-10-28
2025-06-30	$506,069	46,471	+2.2%	Shares	Sole	2025-07-17
2025-03-31	$567,440	45,468	+0.0%	Shares	Sole	2025-04-23
2024-12-31	$900,246	45,467	0.0%	Shares	Sole	2025-01-24
2024-09-30	$371,465	45,467	-15.0%	Shares	Sole	2024-10-22
2024-06-30	$364,110	53,467	+6.6%	Shares	Sole	2024-09-09
2024-03-31	$251,336	50,167	—	Shares	Sole	2024-06-24
No filing history on record for this holder in this stock.